Valganciclovir
NDC 42291-973, Valganciclovir hydrochloride, tablet, film coated, from AvKARE.
- Product NDC
- 42291-973
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200790
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42291-973 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALGANCICLOVIR HYDROCHLORIDE450 mg/1
Pharmacologic classes
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42291-973-60 | 42291097360 | 60 TABLET, FILM COATED in 1 BOTTLE (42291-973-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0d0bbc91-27f6-29bc-e063-6394a90a0027
Use it
Look up 42291-973 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42291-973 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42291-973. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.